Biotech

Mursla Bio joins ABHI US Accelerator for EvoLiver rollout

Programme will support US market access and early clinical adoption of the company’s liver cancer surveillance blood test.

NICE approves first licensed vitiligo treatment for NHS use in England

First licensed vitiligo therapy underscores opportunities for innovation, pipeline prioritisation, and market access in autoimmune skin disorders.

Axol Bioscience acquires Newcells Biotech ophthalmology business

Deal strengthens Axol’s position as a leading independent provider of human iPSC-derived retinal models for drug discovery and safety testing.

SynGenSys Launches Synthetic Promoter Library for Liver-Targeted Gene Therapies

New synthetic promoter tech promises sharper targeting for liver gene therapies

iXCells and Rosebud Team Up on Human Organoid Models

Partnership integrates scalable iPSC workflows with AI-driven 3D organoids to improve drug safety prediction and translational decision-making in rare diseases.

SPT Labtech and Twist Bioscience Team-up to Automate NGS Library Prep Workflows

New validated protocols on SPT’s firefly platform aim to boost throughput and reproducibility for sequencing labs.